关注
Tünde Kovács
Tünde Kovács
在 med.unideb.hu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Microbiome—microbial metabolome—cancer cell interactions in breast cancer—familiar, but unexplored
E Mikó, T Kovács, É Sebő, J Tóth, T Csonka, G Ujlaki, A Sipos, J Szabó, ...
Cells 8 (4), 293, 2019
1672019
Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness
E Mikó, A Vida, T Kovács, G Ujlaki, G Trencsényi, J Márton, Z Sári, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 958-974, 2018
1592018
Cadaverine, a metabolite of the microbiome, reduces breast cancer aggressiveness through trace amino acid receptors
T Kovács, E Mikó, A Vida, É Sebő, J Toth, T Csonka, A Boratkó, G Ujlaki, ...
Scientific reports 9 (1), 1300, 2019
1542019
Lithocholic acid, a metabolite of the microbiome, increases oxidative stress in breast cancer
P Kovács, T Csonka, T Kovács, Z Sári, G Ujlaki, A Sipos, Z Karányi, ...
Cancers 11 (9), 1255, 2019
872019
Indolepropionic acid, a metabolite of the microbiome, has cytostatic properties in breast cancer by activating AHR and PXR receptors and inducing oxidative stress
Z Sári, E Mikó, T Kovács, L Jankó, T Csonka, G Lente, É Sebő, J Tóth, ...
Cancers 12 (9), 2411, 2020
852020
The microbiome as a component of the tumor microenvironment
T Kovács, E Mikó, G Ujlaki, Z Sári, P Bai
Tumor Microenvironment: Recent Advances, 137-153, 2020
812020
Nuclear factor erythroid 2-related factor 2 in regulating cancer metabolism
K Smolková, E Mikó, T Kovács, A Leguina-Ruzzi, A Sipos, P Bai
Antioxidants & Redox Signaling 33 (13), 966-997, 2020
682020
Indoxylsulfate, a metabolite of the microbiome, has cytostatic effects in breast cancer via activation of AHR and PXR receptors and induction of oxidative stress
Z Sári, E Mikó, T Kovács, A Boratkó, G Ujlaki, L Jankó, B Kiss, K Uray, ...
Cancers 12 (10), 2915, 2020
452020
Deletion of poly (ADP‑ribose) polymerase-1 changes the composition of the microbiome in the gut
A Vida, G Kardos, T Kovács, BL Bodrogi, P Bai
Molecular Medicine Reports 18 (5), 4335-4341, 2018
202018
Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging
G Trencsényi, N Dénes, G Nagy, A Kis, A Vida, F Farkas, JP Szabó, ...
Journal of pharmaceutical and biomedical analysis 139, 54-64, 2017
182017
In vivo imaging of experimental melanoma tumors using the novel radiotracer 68Ga-NODAGA-procainamide (PCA)
I Kertész, A Vida, G Nagy, M Emri, A Farkas, A Kis, J Angyal, N Dénes, ...
Journal of Cancer 8 (5), 774, 2017
162017
Silencing of PARP2 blocks autophagic degradation
L Jankó, Z Sári, T Kovács, G Kis, M Szántó, M Antal, G Juhász, P Bai
Cells 9 (2), 380, 2020
132020
Fecal expression of Escherichia coli lysine decarboxylase (LdcC) is downregulated in E-cadherin negative lobular breast carcinoma
Z Sári, T Kovács, T Csonka, M Török, É Sebő, J Tóth, D Tóth, E Mikó, ...
Physiology International 107 (2), 349-358, 2020
122020
Silencing of poly (ADP-ribose) polymerase-2 induces mitochondrial reactive species production and mitochondrial fragmentation
L Jankó, T Kovács, M Laczik, Z Sári, G Ujlaki, G Kis, I Horváth, M Antal, ...
Cells 10 (6), 1387, 2021
72021
Glycogen phosphorylase inhibitor, 2, 3‐bis [(2E)‐3‐(4‐hydroxyphenyl) prop‐2‐enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells
L Nagy, F Béke, L Juhász, T Kovács, É Juhász-Tóth, T Docsa, A Tóth, ...
Plos one 15 (9), e0236081, 2020
52020
Methods to assess the role of poly (ADP-ribose) polymerases in regulating mitochondrial oxidation
E Mikó, T Kovács, T Fodor, P Bai
Poly (ADP-Ribose) Polymerase: Methods and Protocols, 185-200, 2017
32017
4-chloro-orto-cresol activates ryanodine receptor more selectively and potently than 4-chloro-meta-cresol
M Skaliczki, B Lukács, ZÉ Magyar, T Kovács, M Bárdi, S Novák, ...
Cell Calcium 88, 102213, 2020
22020
系统目前无法执行此操作,请稍后再试。
文章 1–17